Risk factors and outcomes of carbapenem-resistant Klebsiella pneumoniae infections
Submitted: 6 October 2016
Accepted: 20 October 2016
Published: 15 December 2016
Accepted: 20 October 2016
Abstract Views: 1862
PDF: 1047
HTML: 1080
HTML: 1080
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Similar Articles
- Matteo Bassetti, Davide Pecori, Maddalena Peghin, Multidrug-resistant Gram-negative bacteria-resistant infections: epidemiology, clinical issues and therapeutic options , Italian Journal of Medicine: Vol. 10 No. 4 (2016)
- Antonio Nouvenne, Andrea Ticinesi, Tiziana Meschi, Carbapenemase-producing Klebsiella pneumoniae in elderly frail patients admitted to medical wards , Italian Journal of Medicine: Vol. 9 No. 2 (2015)
- Ercole Concia, Fulvia Mazzaferri, Maddalena Cordioli, New antibiotic development: barriers and opportunities , Italian Journal of Medicine: Vol. 10 No. 4 (2016)
You may also start an advanced similarity search for this article.